Scholarlink

<p>Glioblastoma (GBM), the most aggressive primary brain tumor in adults, invariably recurs post-radiotherapy despite being a standard treatment. Tumor relapse within irradiated regions is characterized by heightened therapeutic resistance, which we mechanistically link to radiotherapy-induced remodeling of the tumor microenvironment. Here, we demonstrate that ionizing radiation triggers profound senescence in astrocytes, evidenced by β-galactosidase activity, G1 cell cycle arrest, p21 upregulation, and Lamin B1 downregulation. Persistent senescence signatures were observed in GFAP⁺ cells of irradiated mouse brains for ≥ 49 days. Conditioned medium from senescent astrocytes markedly enhanced proliferation, migration, and invasion of GBM cells. Intracranial U251 xenografts in pre-irradiated mice exhibited accelerated tumor growth and reduced survival, phenotypes rescued by the senolytic agent ABT-263. Transcriptomic profiling identified IL6 as the predominant senescence-associated secretory phenotype (SASP) factor elevated in irradiated astrocytes. Senescent conditioned medium activated JAK2/STAT3 signaling in GBM cells, effects abrogated by ABT-263 or tocilizumab (IL6R neutralizing antibody). Functional assays confirmed that IL6 blockade suppressed GBM aggressiveness, mirroring senolytic treatment outcomes. Our findings establish radiation-induced astrocyte senescence as a critical driver of GBM recurrence through IL6-mediated JAK2/STAT3 activation, nominating senolytics as promising adjuvants to improve radiotherapy efficacy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Senescent cell clearance suppresses post-radiotherapy glioblastoma recurrence via the IL-6/JAK2/STAT3 pathway

  • 期刊论文

  • 发表日期：

    2025年12月12日

查看全文
  • Pan Nie,
  • Jiabin Zhou,
  • Jie Zhang,
  • Jincao Chen,
  • Jibo Zhang

摘要

Glioblastoma (GBM), the most aggressive primary brain tumor in adults, invariably recurs post-radiotherapy despite being a standard treatment. Tumor relapse within irradiated regions is characterized by heightened therapeutic resistance, which we mechanistically link to radiotherapy-induced remodeling of the tumor microenvironment. Here, we demonstrate that ionizing radiation triggers profound senescence in astrocytes, evidenced by β-galactosidase activity, G1 cell cycle arrest, p21 upregulation, and Lamin B1 downregulation. Persistent senescence signatures were observed in GFAP⁺ cells of irradiated mouse brains for ≥ 49 days. Conditioned medium from senescent astrocytes markedly enhanced proliferation, migration, and invasion of GBM cells. Intracranial U251 xenografts in pre-irradiated mice exhibited accelerated tumor growth and reduced survival, phenotypes rescued by the senolytic agent ABT-263. Transcriptomic profiling identified IL6 as the predominant senescence-associated secretory phenotype (SASP) factor elevated in irradiated astrocytes. Senescent conditioned medium activated JAK2/STAT3 signaling in GBM cells, effects abrogated by ABT-263 or tocilizumab (IL6R neutralizing antibody). Functional assays confirmed that IL6 blockade suppressed GBM aggressiveness, mirroring senolytic treatment outcomes. Our findings establish radiation-induced astrocyte senescence as a critical driver of GBM recurrence through IL6-mediated JAK2/STAT3 activation, nominating senolytics as promising adjuvants to improve radiotherapy efficacy.